Facebook
Linkedin
Mail
X
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
X
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: AstraZeneca
UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction
12th December 2022
AstraZeneca has today ann...
FARXIGA meets primary endpoint in Phase III DAPA-HF trial
23rd August 2019
AstraZeneca has annou...
Orodispersible tablets of ticagrelor now available in the UK
20th July 2017
AstraZeneca has announced...
NICE recommends dual antiplatelet therapy with ticagrelor and aspirin
4th November 2016
The National Institute of...
